According to a news source, Nordion Inc. has settled a lawsuit in which Bioaxone Biosciences Inc. sought $90 million for the alleged contamination of a spinal cord injury drug with animal products posing a risk of mad cow disease. Bioaxone Biosciences Inc. v. Nordion U.S. Inc., 12-60739 (U.S. Dist. Ct., S.D. Fla., order entered September 19, 2013). Additional details about the case appear in Issue 34 of this Bulletin. The drug was declared adulterated by the Food and Drug Administration and never approved for use in humans. Despite a contract between the plaintiff and defendant specifying that no animal products be used in the creation of the cell bank used to test and develop the defendant’s drug, the defendant allegedly incorporated into the cell bank a raw material containing beef extract and chicken feathers. See Law360, September 23, 2013.